ANGO vs STVN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ANGO · AngioDynamics$11.73 ▼ 0.68%
STVN · Stevanato Group$13.57 ▲ 2.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ANGO -4.5%
- STVN -43.8%
Head to head
| Metric | ANGO | STVN |
|---|---|---|
| Price | $11.73 | $13.57 |
| Change today | ▼ 0.68% | ▲ 2.73% |
| Market cap | $493.30M | $3.71B |
| Return, 3 months | -25.5% | -34.1% |
| Return, year to date | -8.6% | -32.3% |
| Return, 1 year | -2.4% | -43.5% |
| P/E (TTM) | -14.8 | 23.7 |
| P/B | 3.0 | 2.1 |
| P/E percentile vs own 5y | 46th | 43rd |
| Dividend yield | – | 0.45% |
| Revenue growth (YoY, latest qtr) | +6.9% | +7.8% |
| Net profit growth (YoY) | +34.9% | -22.7% |
| Gross margin | 55.7% | 29.2% |
| Operating margin | -6.0% | 17.4% |
| Net margin | -10.1% | 11.0% |
| Return on equity | -19.2% | 9.1% |
| Analyst target vs. price | +62.0% | +71.3% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 39 | 23 |
| 30-day volatility | 79.7% | 102.2% |
| Max drawdown, 1 year | -32.4% | -49.0% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STVN is the largest of the group by market value.
- ANGO has returned the most over the past year.
- ANGO carries the lowest trailing P/E.
- STVN is growing revenue fastest.
- STVN keeps the most profit per dollar of sales.
- ANGO has been the calmest stock over the last 30 days.